Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 09, 2021
Antibiotic resistance (AMR) is not a new problem. However, the global community has been slow to implement recommended policy measures and achieve systemic change. CGD will launch a working group on antimicrobial resistance—seeking to improve antibiotic access and R&D in low- and middle-inc...
Blog Post
October 21, 2021
Poor understanding about vaccine capacity was one of the reasons why the world did not have the infrastructure needed to manufacture sufficient doses. This blogs proposes three actions to start tracking manufacturing capacity better and create robust estimates for the world’s vac...
Blog Post
August 12, 2021
This first episode of the new Africa-centered podcast series Lagos to Mombasa examines how African governments can shape their responses to the pandemic and prepare for the future. Patrick Tippoo of Biovac and the African Vaccine Manufacturing Initiative and Prashant Yadav from CGD join Gyude M...
Blog Post
August 04, 2021
It was the best of times, it was the worst of times, it was the age of vaccines and reopening, it was the age of the Delta variant and closing down again. For many of us, the past year and a half has been stranger than fiction, a whirlwind of emotions and uncertainties. We hope this year's summer re...
Blog Post
June 24, 2021
Most oxygen disasters across India could have been avoided. This blog describes the current model of medical oxygen supply in India, outlines the response to the oxygen crises, including the problem of severe oxygen shortages in some Indian states, and provides recommendations on how India could pre...